Blanket Purchase Agreement V797P7126A-VA24913A0013
Award Date 1/15/13
Last Date to Order 9/30/17
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory reagents, holds a single-award Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs' Veterans Integrated Service Network 12 (VISN 12) for coagulation cost-per-reportable-result (CPRR) testing services. The parent contract, established under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule, carries a ceiling...
- Beckman Coulter, Inc., a subsidiary of Danaher Corporation, was awarded a single-award Blanket Purchase Agreement by Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs, with a ceiling value of $2.518 million and performance period extending through February 28, 2027. The primary deliverable under this indefinite delivery vehicle is automated urinalysis cost-per-reportable-result (CPRR) services, which encompasses provision of urinalysis...
- The federal contract IDV is awarded to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings, by the U.S. Department of Defense's Readiness Center. The contract has a ceiling value of $65,000,000 and a period of performance ending on September 30, 2029. The contract is for the provision of medical laboratory testing services to detect the antigens and antibodies of Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antibody (HBsAb), Hepatitis B...
- This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 17, to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, for the provision of hematology cost-per-reportable-result (CPRR) services. The BPA has a total ceiling value of $2,400,000 and a performance period running through September 14, 2028. The contract was awarded under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule, which...
- This Blanket Purchase Agreement between the Centers for Disease Control and Prevention and Bio-Rad Laboratories establishes an indefinite delivery vehicle to efficiently procure laboratory supplies and equipment through July 2022. Task orders issued against the BPA provide HIV and hepatitis diagnostic test kits, reagents, and specialized instrumentation valued at approximately $282k to support public health monitoring efforts. Places of performance for the tests and reagents are in Atlanta,...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, for the provision of an Antimicrobial Susceptibility Instrument on a cost-per-reportable-result (CPRR) basis. The single-award BPA has a ceiling value of $426,000.00 and an ultimate completion date of December 5, 2025. This award is not set aside and is a Firm Fixed Price contract type. Beckman Coulter, a prominent manufacturer of...
- Beckman Coulter, Inc.'s US Customer Operations Division has been awarded a Blanket Purchase Agreement by the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) for urinalysis cost-per-reportable-result (CPRR) services with a ceiling value of $3.92 million and an ultimate completion date of October 31, 2026. The contract, awarded May 1, 2024, carries no set-aside designation and is a single-award vehicle under the General Services Administration's Critical Analyzers,...
- This Blanket Purchase Agreement (BPA) contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 (VISN 17) to Beckman Coulter, Inc., a subsidiary of Danaher Corporation. The contract, valued at up to $6,488,147.50, is for Beckman Coulter to provide immunochemistry cost-per-reportable-result (CPRR) services to the South Texas Veterans Health Care System. The contract has a period of performance from September 2023 through September 2026 and includes three...
- This Blanket Purchase Agreement (BPA), awarded to Werfen USA LLC on October 1, 2025, establishes a $2.43 million indefinite delivery vehicle with the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) for coagulation cost-per-reportable-result (CPRR) testing services through September 30, 2030. The contract operates under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule and carries no small business set-aside...
- This Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VA VISN 19) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, is for chemistry and immunochemistry cost-per-reportable-result (CPRR) services. The contract, which is not set-aside, has a total ceiling value of $6,892,565.90 and a period of performance from June 1, 2021 to May 31, 2026. Roche Diagnostics holds multiple...
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- V797P7126AFederal Supply Schedule
- V797P7126A-VA24913A0013Blanket Purchase Agreement
- 5Federal Contract Awards
HEPATITIS COST PER REPORTABLE RESULT (CPRR)
Posted 1/22/13
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $0 | 8/5/14 | |
| P00003 | Other Administrative Action | $0 | 10/1/13 | |
| P00001 | Other Administrative Action | $0 | 1/29/13 | |
| Not listed | Not listed | $0 | 1/22/13 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call VA24913A0013-VA24914F0031 | Ortho-Clinical Diagnostics, Inc. | $560.2k | 10/1/13 | 11/6/14 | 10/30/14 | |
BPA Call VA24913A0013-VA24913J0995 | Ortho-Clinical Diagnostics, Inc. | $579.5k | 2/1/13 | 9/30/14 | 5/30/14 | |
BPA Call VA24913A0013-VA24917J20024 | Ortho-Clinical Diagnostics, Inc. | $696.4k | 10/1/16 | 12/31/17 | 10/17/17 | |
BPA Call VA24913A0013-VA24916J24129 | Ortho-Clinical Diagnostics, Inc. | $626.8k | 10/1/15 | 11/30/16 | 11/3/16 | |
BPA Call VA24913A0013-VA24915J3107 | Ortho-Clinical Diagnostics, Inc. | $575.9k | 10/1/14 | 9/30/15 | 10/6/15 |